← Akre Capital Management, latest 13F
Sophia Genetics
In Akre Capital Management's portfolio · John Neff, CEO and CIO
Ticker SOPH
Still in the portfolio as of Q3 2026. Every quarter it shows up in a John Neff, CEO and CIO 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2026 | No change | 3,719,140 | 0.7% |
| Q2 2026 | No change | 3,719,140 | 0.4% |
| Q1 2026 | No change | 3,719,140 | 0.3% |
| Q4 2025 | No change | 3,719,140 | 0.2% |
| Q3 2025 | No change | 3,719,140 | 0.2% |
| Q2 2025 | Add 66% | 3,719,140 | 0.1% |
| Q1 2025 | No change | 2,237,504 | 0.1% |
| Q4 2024 | No change | 2,237,504 | 0.1% |
| Q3 2024 | Add 17% | 2,237,504 | 0.1% |
| Q2 2024 | Add 568% | 1,920,432 | 0.1% |
| Q1 2024 | Buy | 287,699 | 0.0% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.